Company intelligence / Profile preview

Cibus Capital

San Diego, California, United Statescibusfund.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cibus has developed proprietary high-throughput gene editing technologies to create non-GMO plant traits that improve yield and sustainability. The company has several productivity traits in advanced development or commercial integration with major seed companies. Its technology enables faster trait development compared to traditional breeding or GMO approaches.

Therapeutic areas: Other
Modalities: Gene editingBiologic
Industry: Agriculture & AgTech

Partnerships

Major seed companies including GDM Genetics for soybeans and other undisclosed partners in canola and rice markets

Beyond the preview

Go deeper on Cibus Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cibus Capital.

Explore the full profile